Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.785147
Title: Defining the molecular and cellular mechanisms of EZH2's dynamic role in tumourigenesis
Author: Mortimer, Thomas
ISNI:       0000 0004 7970 689X
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2019
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Epigenetic regulators are recurrently hijacked by cancer cells to enhance and maintain their malignant properties. Remarkably, epigenetic regulators are often co-opted by cancer cells in their wild-type unmutated form without any discernible changes to their intrinsic properties. However, the molecular mechanisms that underlie the co-option of these key regulators of cellular identity remain largely unclear. To generate a mechanistic paradigm for this phenomenon, I investigate how the Polycomb component EZH2 transitions from its physiological role in regulating normal development and tissue maintenance, to its pathological role as a tumour promoter. Focussing on the role of EZH2 in the central nervous system, I show that oncogenic signalling redistributes EZH2 on chromatin, leading to transcriptional misregulation of key neural homeotic genes and a malignant rewiring of normal development programmes. This is achieved by de-repression of spinal cord-specifying HOX genes and repression of the forebrain and neural stem cell transcription factor EMX2, an expression switch observed in both glioblastoma cell lines and patient samples. By in vivo assays, I show that EMX2 is a potent tumour suppressor in glioblastoma, suggesting that EMX2 repression by EZH2 is important for glioblastoma maintenance. Beyond its chromatin distribution, I also show that transformation alters the binding partners of EZH2, suggesting that dynamic changes to the composition of Polycomb complexes may promote tumour formation. Thus, by performing a detailed multi-omics characterisation of how neoplastic transformation alters the distribution, activity and binding partners of EZH2, I provide a unique insight into the molecular and cellular mechanisms underlying wild-type EZH2's dynamic role in tumourigenesis.
Supervisor: Scaffidi, P. Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.785147  DOI: Not available
Share: